Rotella Capital Management, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 84 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 6.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rotella Capital Management, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$428,000
-69.3%
63,733
-73.6%
0.38%
-14.9%
Q3 2015$1,394,000
+1133.6%
241,109
+1642.1%
0.45%
+383.9%
Q2 2015$113,000
-90.2%
13,840
-90.2%
0.09%
-90.4%
Q1 2015$1,158,000
+610.4%
141,874
+849.0%
0.97%
+603.6%
Q2 2014$163,00014,9500.14%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Sante Capital Fund, LP 115,637$1,072,0000.44%
Defender Capital, LLC. 135,466$1,255,0000.42%
Green Alpha Advisors, LLC 62,566$580,0000.40%
Harvest Investment Services, LLC 51,239$474,0000.20%
SEVEN EIGHT CAPITAL, LP 118,270$1,096,0000.15%
Cedar Brook Financial Partners, LLC 54,500$505,0000.15%
WASATCH ADVISORS LP 3,576,706$33,156,0000.14%
Banco BTG Pactual S.A. 20,000$185,0000.12%
Keystone Financial Group 60,712$563,0000.10%
Virtus ETF Advisers LLC 25,105$233,0000.10%
View complete list of INOVIO PHARMACEUTICALS INC shareholders